50 results
8-K
EX-99.1
SLS
SELLAS Life Sciences Group Inc
10 Aug 23
SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2023 Financial Results
4:12pm
are expected in the fourth quarter of 2023.
Hosted a virtual expert panel discussion:
SELLAS hosted a virtual expert panel discussion on SLS009 in AML
8-K
EX-99.1
SLS
SELLAS Life Sciences Group Inc
1 Jun 23
Regulation FD Disclosure
4:11pm
Sciences Group. Please go ahead, Angelos.
Angelos Stergiou
Thank you and good morning everyone. Welcome to Sellas’ GFH009 expert panel call.
First
8-K
EX-99.1
smlm8ojzta21dl6ec1w
15 Nov 22
Regulation FD Disclosure
4:15pm
8-K
EX-99.2
q4xrufmqcg9v9zxsn9w
24 Sep 21
SELLAS Life Sciences Announces Settlement of Derivative Litigation
12:00am
8-K
EX-10.1
xaivsi dfe5w
14 Dec 20
SELLAS Announces Pricing of $16.2 Million Registered Direct Offering
6:05am
8-K
EX-10.1
64oltyr4xbyqetm02
4 Aug 20
SELLAS Life Sciences Announces $9.2 Million Private Placement Priced At-The-Market
12:00am
8-K
EX-10.1
l41hg4vqfvvse8r
10 Jan 20
SELLAS Announces Pricing of $6.5 Million Registered Direct Offering Priced At-The-Market
6:03am
8-K
EX-10.1
vmy8vx3dyn
31 Oct 19
Entry into a Material Definitive Agreement
12:00am
424B4
6mvza3
13 Jul 18
Prospectus supplement with pricing info
5:25pm